Announcements Trials
Browse Landscape

Phase

Phase 3 3

Status

Recruiting 3Active not recruiting 2Not yet recruiting 1Completed 1

Sponsor Class

OTHER 6INDUSTRY 1

Study Type

Observational 4Interventional 3

Sponsor

Cancer Type

Gastrointestinal 71Thoracic 31Genitourinary 29Gynecologic 24Breast 23Other hematologic neoplasm 21Lymphoid 21Head & Neck 18CNS 14Dermatologic 10Sarcoma 9Tumor-Agnostic 7Plasma cell 7Myeloid 6Endocrine 6Other 4Classical hematology 4Other solid neoplasm 3Other neoplasm 2

Conditions

Neoplasms 4Neoplasm Metastasis 3

Interventions

pembrolizumab 95Paclitaxel 86Gemcitabine 84Carboplatin 79Surveys and Questionnaires 72Docetaxel 61Bevacizumab 61Nivolumab 59Cisplatin 59Magnetic Resonance Spectroscopy 50Blood Specimen Collection 50Fluorouracil 48Capecitabine 47Radiotherapy 46Irinotecan 40Oxaliplatin 38Erlotinib Hydrochloride 38Biopsy 36atezolizumab 35Leucovorin 35Pemetrexed 34Standard of Care 32Cetuximab 32Specimen Handling 31Trastuzumab 30Radiosurgery 29Ipilimumab 28Cyclophosphamide 28Interviews as Topic 27olaparib 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Observation × Tumor-Agnostic × Clear all
NCT06745024 2026-05-04

Comparing Radiation Therapy to Usual Treatment for Patients With High-Risk Bone Metastases That Are Not Causing Pain, PREEMPT Trial

NRG Oncology

Phase 3 Active not recruiting
280 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT07501871 2026-04-21

DMU-CH

Fenerbahce University

Not yet recruiting
80 enrolled
Tumor-Agnostic

Neoplasms

NCT05061342 2026-01-27

TQ-BIRD

The University of Hong Kong-Shenzhen Hospital

Recruiting
5,000 enrolled
Tumor-Agnostic

Neoplasms

NCT05717166 2025-12-31

SABR-SYNC

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 3 Recruiting
180 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT03721341 2025-09-18

SABR-COMET 10

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 3 Active not recruiting
204 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT06868355 2025-08-14

APACE

University of Manchester

Recruiting
40 enrolled
Tumor-Agnostic

Neoplasms

NCT04060290 2024-02-28

Real-world Study for the Safety of Albumin-Bound Paclitaxel in Malignant Tumors

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Completed
1,000 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡